TEVA 5963 (Guanfacine hydrochloride extended-release 3 mg)
Pill imprint TEVA 5963 has been identified as Guanfacine hydrochloride extended-release 3 mg.
Guanfacine is used in the treatment of adhd; tourette's syndrome; high blood pressure and belongs to the drug class antiadrenergic agents, centrally acting. There is no proven risk in humans during pregnancy. Guanfacine 3 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- TEVA 5963
- Strength:
- 3 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, centrally acting
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA Inc.
More about guanfacine
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
